4//SEC Filing
CD Financial, LLC 4
Accession 0001443197-18-000001
CIK 0001016504other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 5:33 PM ET
Size
7.8 KB
Accession
0001443197-18-000001
Insider Transaction Report
Form 4
INTEGRATED BIOPHARMA INCINBP.OB
CD Financial, LLC
10% Owner
Transactions
- Other
Common Stock
2018-07-31$0.65/sh+8,230,769$5,350,000→ 10,524,173 total - Conversion
6% secured convertible note due 2020, as amended
2018-07-24$5350000.00/sh→ 0 totalExercise: $0.65From: 2012-06-27Exp: 2020-02-20→ Common Stock (8,230,769 underlying)
Footnotes (2)
- [F1]Common stock issued to the Reporting Person as the result of Reporting Person exercising the conversion right under the amended and restated convertible subordinated debt of $5.3 million held by the Reporting Person.
- [F2]On July 31, 2018, the Issuer issued 8,230,769 shares upon the receipt of a conversion notice from the Reporting Person settling the 6% secured convertible note in full.
Documents
Issuer
INTEGRATED BIOPHARMA INC
CIK 0001016504
Entity typeother
IncorporatedFL
Related Parties
1- filerCIK 0001443197
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 5:33 PM ET
- Size
- 7.8 KB